Your browser doesn't support javascript.
loading
The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
Shin, Eui-Cheol; Han, Ji Won; Kang, Wonseok; Kato, Takanobu; Kim, Seong-Jun; Zhong, Jin; Kim, Seungtaek; Park, Su-Hyung; Sung, Pil Soo; Watashi, Koichi; Park, Jun Yong; Windisch, Marc P; Oh, Jong-Won; Wakita, Takaji; Han, Kwang-Hyub; Jang, Sung Key.
Afiliação
  • Shin EC; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Han JW; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Kang W; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
  • Kato T; Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Kim SJ; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
  • Zhong J; Unit of Viral Hepatitis, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
  • Kim S; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Park SH; Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Korea.
  • Sung PS; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Watashi K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
  • Park JY; Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Windisch MP; Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Oh JW; Applied Molecular Virology Laboratory, Institut Pasteur Korea, Seongnam 13488, Korea.
  • Wakita T; Department of Biotechnology, Yonsei University, Seoul 03722, Korea.
  • Han KH; Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Jang SK; Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
Viruses ; 12(3)2020 03 11.
Article em En | MEDLINE | ID: mdl-32168867
ABSTRACT
Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2020 Tipo de documento: Article